- Home
- CII vs CERT Comparison
CII vs CERT Comparison
Compare CII & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CII | CERT |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 841.0M | 860.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CII | CERT |
|---|---|---|
| Price | $24.70 | $6.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 68.5K | ★ 2.5M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 6.17% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $19.44 | $5.19 |
| 52 Week High | $26.17 | $13.88 |
Technical Indicators
Market Signals| Indicator | CII | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 74.42 | 55.41 |
| Support Level | $23.04 | $5.93 |
| Resistance Level | $26.17 | $6.48 |
| Average True Range (ATR) | 0.28 | 0.28 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 98.70 | 76.87 |
Price Performance
Historical ComparisonAbout CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. It may invest directly in such securities or synthetically through the use of derivatives. It also seeks to achieve its investment objective by employing a writing (selling) call and put options.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.